Latest News
Active Energy shares surge on solid interim results
International timber processing, forestry management and renewable energy business Active Energy announced its interim results for the six months to 30 June on Monday, with an 11% increase in revenue to $13. 41m and a 50% increase in gross profit to $1. 84m.
Self-driving vehicle from Google involved in serious crash
A self-driving car made by Google has been involved in a serious accident in California, after the driver of a different car passed through a red light and hit the vehicle.
Nasstar's H1 revenue rises in line with expectations
Nasstar, a provider of hosted managed and cloud computing services, reported a rise in half year revenue as the company was trading in line with management expectations.
City of London's full year losses widen
City of London Group (COLG), an AIM listed investment company that focuses on providing finance to the small and medium enterprises (SME) sector, reported on Monday a deeper annual loss.
US pre-open: Stocks seen weaker as investors eye presidential debate, OPEC
US futures pointed to a downbeat open on Wall Street as investors eyed an OPEC meeting and the first US presidential debate between Hillary Clinton and Donald Trump.
North River Resources shares drop as firm faces uncertainty
Namib Lead-Zinc Project-focused resource company North River Resources posted its unaudited interim results for the six months to 30 June on Monday, with another period of zero revenue as it continued its exploration efforts.
BHS to relaunch as online retailer after store closures
Only one month after its last high street store shut its doors, BHS is set to make a swift comeback as an online shopping outlet.
Samsung to push back Galaxy Note 7 sales restart date
South Korea-based phonemaker Samsung has delayed its reintroduction of its Galaxy Note 7 smartphone to stores in its home country, after the device was recalled following safety issues.
Pfizer says it won't split into two
Following an extensive evaluation, Pfizer has decided not to split the company into two separate publicly-traded groups.
London midday: Stocks fall ahead of OPEC meeting, Trump and Clinton debate
London stocks declined on Monday as investors awaited an OPEC meeting in Algeria and a debate later in the day between Hillary Clinton and Donald Trump.
Europe midday: Banks lead stocks lower as Deutsche slides
European stocks fell on Monday, with banks under the cosh as Deutsche Bank slid, despite a strong reading on German business confidence.
Wetherspoon shares down after chain cancels Christmas dinner
Shares in pub chain JD Wetherspoon were down on Monday morning, after the company announced it was bringing the axe down on the traditional Christmas dinner.
Gemfields' profits soar as production growth continues
AIM listed coloured gem stone miner Gemfields’ full year revenues and profits rose as it increased production at its Zambia and Mozambique emerald and ruby mines.
Deutsche Bank drops on rumours over government back-stop
Deutsche Bank was under the cosh on Monday following reports suggesting that Angela Merkel had ruled out state aid for the lender, despite denials by the company and government.
MJ Gleeson hikes dividend 45% as profit surges
Housebuilder MJ Gleeson hiked its full-year dividend by 45% as profit and revenue in the year to the end of June grew.
Condor Gold 'making good progress' at La India project
AIM listed miner Condor Gold said it was “making good progress” de-risking its Nicaraguan mine as it secured an environmental test for its processing plant during the first half of the year.
Verona Pharma appoints sector veteran Morgan as CFO
AIM listed drug development company Verona Pharma appointed sector veteran Piers John Morgan as chief financial officer on Monday, as the company prepares for clinical trials for its flagship drug.
Goldman Sachs to lay off 30% of Asian investment bankers
US investment bank Goldman Sachs is planning to lay off as much as 30% of its dealmakers in Asia amid falling profits in the region.
Asia report: Markets mostly lower ahead of US debate
Markets in Asia ended lower on Monday, as investors turned their attention towards the first presidential debate in the run-up to the US elections, and an informal meeting of producing members of the OPEC oil cartel.
Numis reiterates 'buy' on Allergy Therapeutics after full year results
Numis reiterated a ‘buy’ rating and target price of 37p on Allergy Therapeutics on Monday after the company reported its full year results.